Alkem Laboratories Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 33,238.7 million compared to INR 30,409.1 million a year ago. Revenue was INR 34,175.1 million compared to INR 30,862.4 million a year ago. Net income was INR 5,949.6 million compared to INR 4,547.1 million a year ago. Basic earnings per share from continuing operations was INR 49.76 compared to INR 38.03 a year ago. Diluted earnings per share from continuing operations was INR 49.76 compared to INR 38.03 a year ago.
For the nine months, sales was INR 97,317.6 million compared to INR 86,966.6 million a year ago. Revenue was INR 99,544.3 million compared to INR 88,440.7 million a year ago. Net income was INR 15,022.1 million compared to INR 9,131.9 million a year ago. Basic earnings per share from continuing operations was INR 125.64 compared to INR 76.38 a year ago. Diluted earnings per share from continuing operations was INR 125.64 compared to INR 76.38 a year ago.